POPULARITY
4 episodes with patient consent
3 episodes with patient consent
3 episodes with patient consent
2 episodes with patient consent
2 episodes with patient consent
2 episodes with patient consent
2 episodes with patient consent
What's the best way to reduce post-op pain after extractions? And why should we never use the term “painkiller” with patients? What to do when you hear the dreaded *crack* of a tuberosity? In this episode we talk about all things post-operative extraction complications! And I'm joined by one of the nicest guys in dentistry - Dr. Nekky Jamal Complications are something we ALL experience, so this episode is great for any dentist. Whether you're brushing up on dry socket prevention, mastering post-op communication, or just curious about advanced healing hacks, tune in for real-world advice to make extractions smoother - for both you and your patients https://youtu.be/BvB3hDESYDY Watch PDP210 on Youtube Protrusive Dental Pearl: The "Niche Kebab" concept encourages dentists to narrow their focus by reducing the variety of procedures they perform and prioritizing those they genuinely enjoy. By evaluating every new skill or treatment added and strategically dropping less-loved procedures, dentists can avoid overextension and the "jack of all trades, master of none" pitfall. Learn how to Extract Impacted 3rd Molars, don't miss out on Third Molars Online and use the coupon code ‘protrusive' to get 15% off! Key Takeaways Pain management is about setting realistic expectations. Dexamethasone can be beneficial but must be used cautiously. Dry socket is often overhyped; proper care can prevent it. Effective communication can alleviate patient anxiety and prevent misunderstandings and complaints. Preoperative care can help manage pain expectations. Understanding the signs of infection is essential for diagnosis. Chlorhexidine rinses can significantly reduce dry socket risk. Patients appreciate being informed about their unique dental situations. PRF can significantly reduce the incidence of dry socket. Dentists should embrace new techniques like PRF to enhance patient care. Patient involvement in post-surgical care is crucial for healing. Dentists should not hesitate to refer complex cases to specialists. Highlights of this episode: 02:54 Protrusive Dental Pearl 04:05 Dr. Nekky Jamal 08:39 Managing Post-Extraction Pain and Swelling 21:37 Infection 25:02 Identifying Dry Socket and How to Prevent it 28:30 Case Selection and Communication 37:13 Mitigating Dry Socket with Platelet-Rich Fibrin (PRF) 39:47 The Importance of Nicheing in Dentistry 43:19 Cryotherapy and Post-Surgery Care 47:32 Handling Tuberosity Fractures 55:08 Patient Consent 57:55 Litigation and Patient Communication This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance. This episode meets GDC Outcomes A, C and D. AGD Subject Code: 310 ORAL AND MAXILLOFACIALSURGERY (Exodontia) Dentists will be able to: Identify and differentiate common postoperative complications, and recognise the key symptoms associated Evaluate the ethical and clinical considerations of case selection for extractions Communicate effectively with patients regarding potential complications If you loved this episode, be sure to check out another epic episode with Dr. Nekky Jamal - Wisdom Teeth Extractions – SURGICAL TOP TIPS
Welcome to another episode of "Restoring the Soul with Michael John Cusick." In today's episode, we'll explore the critical concept of trauma-informed care—a term that's become widespread yet is often misunderstood. Originating from clinical and research settings and gaining broader cultural awareness, trauma-informed care prioritizes understanding the comprehensive life experiences of individuals to improve their engagement and outcomes in care settings.Michael shares personal stories that underscore the importance of this approach, illustrating the profound impact it can have on patient experiences and outcomes. We'll delve into practical ways organizations can create sensitive environments for those with neurodiversity and sensory sensitivities, the significance of establishing clear protocols for consent and empowerment, and the necessity of training staff in trauma-informed practices.Join us as we discuss how integrating trauma-informed care can lead to better engagement, retention, and overall health outcomes, transforming the way we approach care in both medical and therapeutic environments.ENGAGE THE RESTORING THE SOUL PODCAST:- Follow us on YouTube - Tweet us at @michaeljcusick and @PodcastRTS- Like us on Facebook- Follow us on Instagram & Twitter- Follow Michael on Twitter- Email us at info@restoringthesoul.com Thanks for listening!
In this episode of The Standard of Care podcast, hosts Samantha Johnson and Nick Adams delve into the complex legal framework of patient consent in EMS. What happens when a patient refuses care, even in life-threatening situations? How should EMS professionals navigate the fine line between consent, implied consent, and refusal, all while staying within the legal boundaries? Samantha quizzes Nick on real-world scenarios, offering practical insights on handling refusals, informed consent, and what EMS providers need to know about patient capacity.Whether you're a seasoned paramedic, new to the field, or just brushing up for the National Registry exam, this episode offers valuable knowledge on critical issues you may face. Get actionable advice, hear relatable examples, and understand the nuances that could impact your next decision. Tune in now to explore this important topic—and remember, you can find The Standard of Care wherever you listen to podcasts or on our website at flightbridgeed.com/explore. While you're there, check out our award-winning courses designed to enhance your professional skills and knowledge.Key Takeaways:Understanding patient capacity is critical in determining whether you can proceed with care, even if consent is initially given. If a patient has capacity, their refusal must be respected, even in life-threatening situations.Implied consent allows EMS providers to intervene in emergencies when a patient is unconscious or unable to give explicit consent, but only within the necessary scope of care.Informed refusals are equally important as informed consent. EMS professionals must ensure patients fully understand the risks of refusing care and document everything thoroughly.
AI is revolutionizing healthcare by analyzing massive datasets to uncover hidden patterns, leading to breakthroughs in disease diagnosis, treatment, and patient care. Join Jennifer Johnson and Jamal Khan as they explore AI's impact on healthcare. They delve into critical ethical considerations, governance structures, data security measures, and AI's role in clinical decision support. Speakers: Jennifer Johnson, Director of Healthcare Strategy and Business Development at Connection Jamal Kahn, Chief Growth and Innovation Officer at Connection Show Notes 00:00 Introduction and AI Ecosystem Shifts 02:07 Ethical Considerations and Governance in AI Healthcare 05:49 Challenges of Data Poisoning and Model Drift in AI Healthcare 08:02 Role of CAIOs in Healthcare Governance and Data Strategy 10:48 Importance of Patient Consent and Cross-Jurisdictional Challenges 13:01AI's Impact on Healthcare Provider Work Environment 17:45 Vetting AI Partners and Virtual Assistants in Healthcare 19:39 Patient Accessibility and Engagement in Healthcare 22:50 Clinical Trials and Technology in Healthcare 24:13 Challenges of Merging Patient Data in Healthcare 27:01 AI Adoption in Healthcare: Impact on Insurance Providers 32:08 Challenges of Transparency and Explainability in AI 35:58 AI in Clinical Settings: Promising Use Cases 37:18 Choosing Hyperscalers for Healthcare AI Implementation 48:01 Data Orchestration for Patient Care with AI 50:17 Following Patients Through Care Settings with AI 52:08 Excitement and Challenges of AI Integration in Healthcare
Welcome to the Paint The Medical Picture Podcast, created and hosted by Sonal Patel, CPMA, CPC, CMC, ICD-10-CM. Thanks to all of you for making this a Top 15 Podcast for 3 Years: https://blog.feedspot.com/medical_billing_and_coding_podcasts/ I'd love your continued support of this content-rich, value-add podcast to help you succeed in the business of medicine: https://podcasters.spotify.com/pod/show/sonal-patel5/support Sonal's 11th Season starts up and Episode 15 features a Newsworthy update on the OIG Work Plan for March 2024. Sonal's Trusty Tip and compliance recommendations focus on hospital policy revisions on informed patient consent. Spark inspires us all to reflect on quantity versus quality based on the inspirational words of William A. Foster. Thanks to Advanced Coding Services: Website: https://advancedcodingservices.com/ Paint The Medical Picture Podcast now on: Spotify for Podcasters: https://podcasters.spotify.com/pod/show/sonal-patel5 Spotify: https://open.spotify.com/show/6hcJAHHrqNLo9UmKtqRP3X Apple Podcasts: https://podcasts.apple.com/us/podcast/paint-the-medical-picture-podcast/id1530442177 Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy8zMGYyMmZiYy9wb2RjYXN0L3Jzcw== Amazon Music: https://music.amazon.com/podcasts/bc6146d7-3d30-4b73-ae7f-d77d6046fe6a/paint-the-medical-picture-podcast Breaker: https://www.breaker.audio/paint-the-medical-picture-podcast Pocket Casts: https://pca.st/tcwfkshx Radio Public: https://radiopublic.com/paint-the-medical-picture-podcast-WRZvAw Find Paint The Medical Picture Podcast on YouTube: https://www.youtube.com/channel/UCzNUxmYdIU_U8I5hP91Kk7A Find Sonal on LinkedIn: https://www.linkedin.com/in/sonapate/ And checkout the website: https://paintthemedicalpicturepodcast.com/ If you'd like to be a sponsor of the Paint The Medical Picture Podcast series, please contact Sonal directly for pricing: PaintTheMedicalPicturePodcast@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/sonal-patel5/message Support this podcast: https://podcasters.spotify.com/pod/show/sonal-patel5/support
Managing patient expectations in Dentistry - there are some MAJOR lessons we can learn from facial aesthetics practitioners. We're diving into a conversation with Dr. Katherine Bell that's really going to open your eyes about communication. Despite beauty being subjective, we find a lot of similarities in how we talk to and get consent from patients, whether it's for facial aesthetics or dental procedures So, even if facial aesthetics isn't your cup of tea, think of this episode as a deep dive into communication and consent. Plus, it's Documentation Month on Protrusive Podcast, and this episode is just the beginning! https://youtu.be/28hRaMARgnA Watch PDP180 on Youtube Protrusive Dental Pearl: Tailoring consent to each patient involves discussing only the risks that matter to them, using standard forms for GUIDANCE, not for completeness. It's about clearly explaining how we'll minimize these risks, ensuring the patient feels secure and informed about the precautions taken. For example ‘Mrs Smith, your tooth is very badly broken down and this can be a very tricky extraction. The way we are going to make it easier is by carefully dividing the tooth in to 3 roots' Highlights of this episode: 01:36 Protrusive Dental Pearl 03:33 Dr. Kathryn Bell Introduction 05:01 Dr. Kathryn Bell's Journey in Facial Aesthetics 09:08 Perception of Facial Aesthetics 15:34 Discussion on Documentation and Patient Education 20:05 Patient Consent and Managing Risks 25:13 Screening for Body Dysmorphia 33:50 Considerations for Patients with Depression Seeking Aesthetic Treatments 38:06 Learn More with Dr. Kathryn Bell Access the CPD quiz through our app on https://www.protrusive.app, either on your browser or by downloading our mobile app. For the full educational experience, our Ultimate Education Plan gives you access to all our courses, webinars, and exclusive monthly content. Join us on Protrusive Guidance, our own platform for dental professionals. No need for Facebook anymore! ;-) If you loved this episode, be sure to watch Botox for TMD – Indications and Protocols
In this episode of the Back Table MSK podcast, co-hosts and interventional radiologists Dr. Aaron Fritts and Dr. Chris Beck have an in-depth discussion about bone marrow biopsies, including their preferred techniques and devices, potential complications, and management of patient expectations. To start, they cover the typical referral pathway for biopsies, the majority of which involve hematology/oncology indications. Preoperatively, managing patient expectations is important to communicate, especially regarding sedation and pain control. The IRs also walk through the biopsy steps, anatomy of the ilium, and confirmatory imaging with CT and fluoroscopy. They also share their experiences with different biopsy needles such as the OnControl, Jamshid, and Trek systems. There are advantages to using a system that comes with a powered drill, but these can also increase patient anxiety. Additionally, it is important to consider the bone density of the patient when selecting the tool. A manual system may offer sufficient force for demineralized or osteoporotic bone. The hosts also discuss potential unintended outcomes of the procedure, including dry taps and entry into joints or sacral foramina. Finally, they review post-procedural care and patient emergence from sedation. --- SHOW NOTES 00:00 Introduction 03:36 Indications for Biopsy 05:40 Patient Consent and Sedation 13:58 Procedural Steps and Confirmatory Imaging 27:04 Comparison of Different Biopsy Tools 36:11 Dealing with Complications 41:00 Post-Procedural Care --- RESOURCES BackTable VI Episode 381- Anesthesia vs. Moderate Sedation: A Spectrum of Care with Dr. Vishal Kumar: https://www.backtable.com/shows/vi/podcasts/381/anesthesia-vs-moderate-sedation-a-spectrum-of-care OnControl Powered Bone Biopsy System: https://oncontrolsystem.com/ Jamshidi Evolve Bone Marrow Needle: https://www.bd.com/en-us/products-and-solutions/products/product-families/jamshidi-evolve-bone-marrow-needle Trek Powered Bone Biopsy System: https://www.bd.com/en-us/products-and-solutions/products/product-families/bd-trek-powered-bone-biopsy-system
Hosts Ken Kleinberg and Jocelyn Keegan from Point-of-Care Partners (POCP), healthcare technology enthusiasts were treated to an engaging discussion with a special guest, Alice O'Carroll, Interoperability Product Manager at Florida Blue. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
On this episode of "The Dish on Health IT," hosted by Ken Kleinberg and Jocelyn Keegan from Point-of-Care Partners (POCP), healthcare technology enthusiasts were treated to an engaging discussion with a special guest, Alice O'Carroll, Interoperability Product Manager at Florida Blue. Ken Kleinberg, the senior consultant and innovation lead at POCP, kickstarted the episode by extending a warm welcome to listeners, emphasizing POCP's pivotal role as trusted and independent health IT consultants. He expressed their unwavering dedication to uncovering the latest healthcare technology news and milestones.The episode promised an illuminating exploration of some of healthcare's most significant challenges and opportunities from a payer perspective including:• CMS MANDATES IN HEALTH IT: Ken introduced the episode by shedding light on the far-reaching impact of CMS mandates and other policy initiatives within the healthcare technology space. The hosts emphasized that merely adhering to regulations falls short; healthcare stakeholders must aspire to achieve more.• ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE IT: The episode delved into the transformative potential of AI in healthcare but perhaps used in a more mundane way than expected. • ENHANCING DATA QUALITY IN HEALTHCARE: The hosts underlined the paramount importance of elevating data quality standards within healthcare. They highlighted how this mission not only benefits healthcare providers and payers but also empowers patients and enhances overall healthcare outcomes.• PATIENT CONSENT MANAGEMENT IN DIGITAL HEALTH: Among the critical issues discussed was the management of patient consent not only across the ecosystem but also the need for the patient to be able to grant access to pieces of information and not their full record. Most importantly, patients need a way to revoke consent at any time. Consent is a challenge demanding immediate attention within healthcare technology.Alice O'Carroll's introduction was met with enthusiasm as she joined the podcast as a distinguished guest. She donned multiple hats, including her role as the Interoperability Product Manager at Florida Blue and her status as one of the champions of the HL7 Da Vinci Project—a remarkable collaborative initiative. Alice passionately shared her personal dedication to healthcare interoperability, tracing her journey into the realm of interoperability mandates and their profound impact. She underscored the unique role of these mandates in reshaping the entire business model of health IT. She explained that she had a deep belief that interoperability can usher in meaningful change, benefiting not only patients but also all stakeholders in the healthcare ecosystem.At Florida Blue, Alice and her team stood at the forefront of CMS mandate compliance, actively participating in industry workgroups like Da Vinci to ensure alignment with industry standards and drive positive transformation.The discussion swiftly transitioned to the impact of policy developments, particularly CMS mandates, on payers in the healthcare technology landscape. Alice offered her perspective, tracing the lineage of mandates back to CMS's Meaningful Use initiative. She painted a vivid picture of a rapidly evolving regulatory landscape, touching upon mandates such as the transparency and coverage mandate and the no-surprises act. Alice emphasized the vital role of industry involvement in effectively influencing and navigating these transformative regulations.Ken questioned the philosophy of merely checking the regulatory box and explored why organizations, including Florida Blue, should invest additional time and resources in healthcare technology. Alice passionately responded, underlining that the healthcare technology industry's business model is undergoing a profound shift. She explained that compliance with mandates like USCDI creates opportunities, such as payer-to-payer data exchange, but real value emerges from leveraging data to benefit members, lower costs, and enhance quality.The trio ventured into the thrilling domain of artificial intelligence (AI) in healthcare technology. Ken and Jocelyn recognized the potential and challenges AI presents. Alice joined in, envisioning AI's role in transforming unstructured data into structured data, thus enhancing data quality and interoperability in healthcare technology.Alice and Jocelyn delved deeper into the pivotal topic of data quality, acknowledging the healthcare technology industry's historical shortcomings. Alice stressed the need for a universal standard and the challenges posed by unstructured data. She discussed how regulations accelerated data exchange but also emphasized the significance of data stewardship and accountability in healthcare technology.This dynamic conversation encapsulated these crucial healthcare technology themes, painting a vivid picture of an industry undergoing unprecedented transformation. As Ken, Jocelyn, and Alice shared their insights, they collectively illuminated a path forward—one where interoperability, data quality, AI and consent management converge to progress healthcare towards a more patient-centered approach. The podcast culminated with a valuable reminder from Alice and Jocelyn for healthcare technology professionals to actively engage in industry workgroups and partake in the ongoing transformation of healthcare data sharing and interoperability. They championed a collaborative approach, where both business and IT partners collaborate effectively to navigate the evolving healthcare technology landscape.In closing, Ken expressed his gratitude to his guests, Jocelyn Keegan and Alice O'Carroll, for their passionate insights and engagement in the healthcare technology discussion. He also extended his thanks to the audience for tuning in and invited them to stay updated with future podcast episodes across various platforms as the dynamic field of health IT and healthcare technology continues to evolve.
In this episode, Patron Saint of The Side Woo, Nikki Nolan shares her story about how she began advocating for patient rights, specifically a requirement for stricter regulations around medical consent. After a traumatic experience with a Bay Area medical facility in which her requests for an all-female staff during an ob-gyn procedure were denied, Nikki began researching how to implement policies that favor the agency of patients within medical institutions. Sarah shares her own traumatic experiences within the medical industry. And Nikki and Sarah discuss the benefits of having an internal locus of control on one's sense of self-worth, and self-efficacy and how patient consent will help to further that in vulnerable populations. About Nikki Nolan Nikki Nolan is a conceptual artist, designer, and podcaster based in Oakland, CA. Her thought-provoking work tackles important social issues, exemplified in her two podcasts, "Matter of Life and Debt" and "Disability Bandwidth". Nikki holds a master's degree in art with a specialization in interactive media from Pratt Institute, where she explored the effects of online media on human memory. She also has a bachelor's degree in sculpture and photography and a certificate in web development. Through her passion for art, design, and podcasting, Nikki Nolan inspires others to innovate with her unique perspective. Show Notes https://nnolan.com/ Nikki Nolan's Instagram https://www.instagram.com/thenikkinolan/ Nikki Nolan's LinkedIn https://www.linkedin.com/in/nikkinolan/ Matter of Life and Debt Podcast https://matteroflifeanddebt.com/ Disability Bandwidth Podcast https://disabilitybandwidth.com/ About The Side Woo Host & Creator: Sarah Thibault Host: Elizabeth Bernstein Sound & Content editing: Sarah Thibault Intro and outro music: LewisP-Audio found on Audio Jungle, Sound Effect from Pixabay The Side Woo is a podcast created through The Side Woo Collective. To learn more go to thesidewoo.com For questions, comments, press, or sponsorships you can email thesidewoo@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/thesidewoopodcast/message Support this podcast: https://podcasters.spotify.com/pod/show/thesidewoopodcast/support
There are multiple factors to consider when obtaining valid consent from a patient. In my view, the most important aspects to consider are ensuring that you've got all of the alternative treatments documented and shared with the patient prior to the commencement of treatment, that obviously forms the backbone, these multiple treatment choices were potentially possible. But the depth to obtain valid consent is ensuring that the patient understands the risks and benefits of each of the treatment alternatives. This is where consent can become quite complex in nature. If you start to envisage them from the patient's perspective, as long as they are feeling like they are being involved in the decision, once they've got an understanding of the treatment options available to them and they're then aware of the risks of each treatment option and they're willing to accept the risks associated with the treatment option that they prefer, we're still moving slowly and surely towards the stages, if required to get informed consent. And I think these form the key factors, so that patients feel like they're part of the process. And they are part of the decision making process in particular. The challenge, of course, is most doctors have a very limited time to be able to have this discussion in detail. A lot of the consent process is done with the aid of consent forms. Of course, the challenge with a consent form is that it is usually quite complex and difficult for a patient to understand. Just by simply getting a signature from a patient doesn't necessarily demonstrate, retrospectively, that valid consent was obtained. In my opinion, the key parts to demonstrating that valid consent was taken is the number of stages that were involved. It might start with a high level discussion, information leaflets, recommendations for the patients to either speak to family and friends about the decision, or possibly do their own further reading around it, subject to your advice, so that they can get a better understanding. Of course, nobody can make decisions instantly or even on the same day. We all need time to consider the treatment options. For the purposes of thinking about your process of obtaining valid consent, put yourself in the shoes of a patient and consider a treatment outside of your area of expertise. For example, if you're an IT specialist, think about giving consent for an orthopedic procedure. If you're an orthopedic surgeon, think about having a dental procedure and think about all of the things that you would like to know, within that area that's outside of your area of expertise. Before you were able to make a decision, you'd want to know what the alternatives are. You'd want to know which recommendation that the actual provider of the care is suggesting. In the context of the alternative, they might say we think Option A is the way to go. But this is weighed up against the risks or benefits of option B, C, and D, so that both parties are actually making a decision. The biggest problem I've seen from consent not being valid is that the patient feels like things were being done to them as if they felt like they weren't part of that process. And it goes to an even more philosophical level that the patient doesn't feel like they were heard, they didn't feel like their position, or their feelings, or their interests were put forward. They were rather just told you're going to have to have this procedure done and sign this piece of paper, and we'll get it done. That's not valid consent. Although it might feel like you've got a signature. Think back to the last time you've hired a vehicle from a car rental company. Do you ever feel that you've truly understood all of the risks and benefits and risks associated with hiring a car when you're presented with a 10 or sometimes small print three or four side document that will go through all the disclaimers and all of the the finer details associated with the rental of a car. You may
Part 2 of our interview with Dr. Drew Cronyn, pediatrician and clinical director at Transhealth in Northampton, Massachusetts where we continue our discussion on providing general and specialized affirming care for transgender, gender-creative, nonbinary, and gender-questioning youth.
In this episode we discuss the General Practice Data for Planning and Research (GPDPR) and the extension of the deadline for it to come into play. Hear from: Phil Booth, coordinator, MedConfedential Osman Bhatti, east London GP Anne Marie Cunningham, GP in Wales and CCIO Network member Andrea Downey, senior reporter, Digital Health
Ali Loveys, MD, FAAP, FHIMSS, ABP-CI is the Chief Privacy Officer, Foundation Relations and North American Markets Leader at Consensys Health. Ali is board-certified in clinical informatics and has had tons of experience as Chief Medical information officer at multiple organizations. During 2018-2020, she was Managing Director Federal Practice Digital Health and US Healthcare Blockchain Leader at Ernst and Young. In this episode we talked bout healthcare, data, cybersecurity, AI, and blockchain. Disclaimer: Remember, the Health Unchained podcast is for informational and entertainment purposes only and we are not providing any sort of legal, financial, or medical advice. Please do your own research and due diligence before making any important decisions related to these matters. Show Notes •Introduction of Ali's background •Journey into technology, business, and healthcare in your career •Working on the RHIO (Rochester Health Information Organization) •Experience at EY as digital healthcare blockchain lead •COVID19 affect on the healthcare data and public trust •Describe your role at ConsenSys Health •When did you first hear about blockchain? •How do we bridge the gap between technology and healthcare? •How is blockchain adoption and awareness in healthcare developing in the US? •Biggest misconceptions of blockchain from various healthcare executives •How important is community governance when developing a DLT solution? •Why should people care about their data privacy? •Patient Consent data sharing •What can we do about unread Terms of Service and Privacy Policies? It feels like we don't really have a choice if we want to use many tech platforms. •Data privacy - Realistic technology expectations - HIPAA and GDPR •Ethical Responsibilities for AI development and big data in Healthcare •Industry Partners - existing partners and pilot projects •What do you believe in that most people would disagree with? •If it’s not too personal, what would you consider to be your biggest mistake? •Favorite book - Historical non-fiction •If you had to have micro chip implanted in your body, where would you want it to be implanted? •Final Takeaways Health Unchained News Corner The US Department of Health and Human Services announced its blockchain platform called HHS Protect to collect and share Covid-19 hospitalization data. HHS Chief Information Officer, Jose Arrieta, has been leading efforts at HHS to use blockchain to secure, validate, and share procurement data for a few years now. According to the CIO, HHS Protect coordinates data from 6,200 hospitals across the United States, including numbers of ventilators, hospital beds, ER admittance, and discharge, lab test data across the U.S., warehouse implications, and nursing home data. https://www.forbes.com/sites/jasonbrett/2020/07/24/us-health-department-chief-discloses-functioning-blockchain-project-to-track-covid-19/#26cc64e01949 https://protect-public.hhs.gov/ Health Unchained Links Website: https://healthunchained.org Telegram: t.me/healthunchained Twitter: twitter.com/Healthunchaind Bert’s Blockchain and Healthcare Weekly Newsletter: https://bert.substack.com/
The discussion continues with guest, Dr. Tim Pletcher, Executive Director of the Michigan Health Information Network Shared Services (MiHIN) joins The Dish on Health IT panel of senior consultants, Gary Austin, Jocelyn Keegan and Ken Kleinberg to discuss the role of Health Information Exchanges in healthcare, their role in the response to COVID-19 and what role they can serve in the future once TEFCA is finalized. Part 2 of the discussion jumps in with how MiHIN responded to COVID-19 by creating a separate group to serve public health needs during the crisis. MiHIN also created a telehealth service to better serve patients and support stay at home orders. Dr. Pletcher explained they acceleration the connections with labs and expressed his desire for results to be sent back via API instead of batch files to expedite results availability. Data links and analytics have taken on a whole new role during this time. MiHIN has taken on a support role which may have pumped the brakes on some innovation projects but there has been opportunity to increase the priority of other projects that could directly positively impact the pandemic response. Jocelyn explained why its so important to meet people where they are in order to make progress. This time is also a time for these simulated barriers to drop. She asked Dr. Pletcher how MiHIN is dealing with perceived security issues when working with innovation projects or partnering with new stakeholders. Dr. Pletcher responded by saying that their biggest challenge right now are Quest and Labcorp because they don't like to share data but this will be resolved through government intervention. The issues generally are not technical issues but business issues with one partner either not wanting to share data or restricting how the data can be used. The group went on to discuss how dropping the rules to facilitate the use of telehealth more readily will be a huge driver for change and innovation and hopefully the rules will remain suspended because patients should have more access via telehealth even over state lines. The conversation moved to data blocking with Gary pointing out EHRs are usually the ones getting the finger pointed at them for data blocking. Dr. Pletcher expressed that Epic or Cerner have never blocked or withheld data in Michigan so he doesn't know who it really is doing the data blocking. Will the US do more around pandemic surveillance like Taiwan and South Korea? Will HIEs support something like? Ken pointed out that some people don't want to be tracked in this way and will opt out or avoid it, however, if it's the only way a person is allowed to get into a ball game or something, they likely will. Dr. Pletcher explained that opt-in and opt-out is an archaic concept. There is a much better framework which would allow patients to express a more granular desire of how they want their data to be used. Doctors have choices too and when patients consent to receive treatment, physician choices come into play. The group highlighted where there are similarities between the financial and healthcare industries related to security and data access until the complexities of healthcare ends the similarities with identity being a major hurdle. With the explosion of patient apps, there is also a trust factor the that comes into play as far as understanding what data that can be obtained from patients apps can be trusted and whether they will look at HIEs as the consolidator of data vs going to Payers.
The panel and guest, David Szabo, Co-Chair of the Health Care practice, a Partner in the Corporate and Transactional Department, and a member of the Privacy & Cybersecurity Practice Group with Locke Lord, LLP continued the discussion from Part 1 by shifting the focus to the complexities of price transparency. Not only with what data is needed to provide meaningful information about the price patient's can expect to pay but to how widely this information should be expected to be shared without crossing a line to reveal contract details that companies may feel are proprietary. There has been a push by this administration to increase transparency of contract prices as well. This has been responded to in a patchwork of approaches. Ultimately, the panelists and guest agreed that the importance and impact of price transparency on patients is different in situations whether the patient is experiencing a chronic illness or an acute episode. When a patient is in the middle of an emergency shopping around for price goes out the window. Price transparency for chronic or scheduled elective procedures may be where work around meaningful price transparency will progress more quickly. The panelists and guest then moved to discuss data privacy and patient consent. As patients begin to adopt 3rd party health apps and consent for their physicians to share their data with these 3rd party applications, data privacy no longer falls under HIPAA. Physicians may play a role in encouraging patients to carefully read privacy policies for these apps, however, physicians ultimately don't have any control over what the patient chooses to do with their data. The discussion talked about the philosophy driving these rules is the fervent belief that the more data patients have, the better decisions they will make which remains to be seen. Data in these apps could be used by pharmaceutical companies to better track efficacy data in the real world. Will FTC have a bigger role in enforcement/protection of health data shared with 3rd party apps? Szabo felt that congress would need to grant more powers to FTC for them to get into the role of mandating a minimum amount of protections versus their current role which is to investigate after a breach or misuse of data has already occurred.What should payers, health IT vendors, and providers be doing? Szabo recommends that everyone get ready. Have an interoperability policy that addresses your obligations and lays out a framework for the rules and exceptions. Ken added that stakeholders should take this time to consider how their policies and long term health IT strategies will make healthcare better rather than meet the minimum regulations requirements.
This month we answer questions on: GDPR patient consent, marketing denture patients, handling membership patients that FTA, how to work better with hygienists’ and how to discuss whitening with existing patients.
Every year, commercial testing labs earn millions of dollars from selling the anonymized results of blood, urine, tissue, and other tests with almost no public scrutiny or debate.2 Few outside the industry know anything about this trade, and lab workers are often in the dark as well.
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events This entry provides an audio source for iTunes U.
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events This entry provides an audio source for iTunes U.
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events This entry provides an audio source for iTunes U.
Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The The Baron de Lancey Medical Law Lecture 2016 was delivered on 5 February 2016 by Mr James Badenoch QC who acted as counsel for the successful appellant before the UK Supreme Court in Montgomery v Lanarkshire Health Board [2015] UKSC 11, and was entitled "Montgomery: a dramatic change in the law on patient consent?". In his lecture James Badenoch outlined the state of the law before the decision in Montgomery and the numerous ways in which it had failed to pay attention to the key distinction, recognised by the Supreme Court in Montgomery, between cases concerning disclosure of information and those concerning the application of medical skill and expertise. He went on to suggest that the decisive break achieved in Montgomery may well prove an apt footing on which to challenge the long-held authority of the so-called 'Bolam' test for whether a medical practitioner has been negligent in situations outside of that considered in Montgomery. For more information about the Baron de Lancey Medical Law Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events
© 2020-2025 Ivy Podcast Discovery LLC
